Fintel reports that on October 8, 2025, Evercore ISI Group maintained coverage of Quest Diagnostics (NYSE:DGX) with a In-Line ...
In the latest quarter, 7 analysts provided ratings for Quest Diagnostics (NYSE: DGX ), showcasing a mix of bullish and ...
Evercore ISI raised the firm’s price target on Quest Diagnostics (DGX) to $190 from $185 and keeps an In Line rating on the shares as the firm ...
The Animal Auto-Immune Disease Diagnostics Market is witnessing significant growth, estimated at USD 6.2 billion in 2025 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results